AR033151A1 - Agente para el tratamiento oftalmico topico de las enfermedades inflamatorias oculares - Google Patents
Agente para el tratamiento oftalmico topico de las enfermedades inflamatorias ocularesInfo
- Publication number
- AR033151A1 AR033151A1 ARP020101334A ARP020101334A AR033151A1 AR 033151 A1 AR033151 A1 AR 033151A1 AR P020101334 A ARP020101334 A AR P020101334A AR P020101334 A ARP020101334 A AR P020101334A AR 033151 A1 AR033151 A1 AR 033151A1
- Authority
- AR
- Argentina
- Prior art keywords
- agent
- inflammatory
- present agent
- ophthalmic treatment
- eye
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
La presente provee un agente para el tratamiento oftálmico topico de un ser humano para enfermedades inflamatorias oculares, que contiene un compuesto como se muestra en la formula general (1) o sus sales farmacéuticamente aceptables como el ingrediente activo en la concentracion de 0,01% a 0,1%. El presente agente para el tratamiento oftálmico topico muestra continuamente efectos antiinflamatorios oculares superiores mediante la administracion topica en una dosis baja al ojo de un ser humano que tiene enfermedades inflamatorias oculares. El presente agente es efectivo para síntomas causados por la enfermedad inflamatoria ocular tales como picazon, ardor, edema, ulcera, etc. El presente agente también es efectivo para un sujeto en el cual los agentes antiinflamatorios no muestran un efecto de mejora (por ej., esteroides y ciclosporinas). El presente agente también es efectivo para un sujeto para el cual no se pueden usar otros agentes antinflamatorios (por ej., contraindicacion de esteroides). El presente agente es muy util especialmente por la razon de que muestra suficientes efectos mediante la administracion topica al ojo durante una a cuatro veces.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28316901P | 2001-04-12 | 2001-04-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR033151A1 true AR033151A1 (es) | 2003-12-03 |
Family
ID=23084835
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP020101334A AR033151A1 (es) | 2001-04-12 | 2002-04-11 | Agente para el tratamiento oftalmico topico de las enfermedades inflamatorias oculares |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20020187998A1 (es) |
| EP (1) | EP1379247A1 (es) |
| JP (1) | JP2004529928A (es) |
| KR (1) | KR20040007494A (es) |
| CN (1) | CN1503671A (es) |
| AR (1) | AR033151A1 (es) |
| BR (1) | BR0208939A (es) |
| CA (1) | CA2445508A1 (es) |
| MX (1) | MXPA03009273A (es) |
| NO (1) | NO20034560L (es) |
| NZ (1) | NZ529255A (es) |
| WO (1) | WO2002085359A1 (es) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ530845A (en) | 2001-07-06 | 2006-03-31 | Sucampo Ag | Composition for topical administration |
| KR20040066825A (ko) * | 2001-11-19 | 2004-07-27 | 노파르티스 아게 | 아스코마이신의 안검염 치료 용도 |
| US20050239813A1 (en) * | 2002-08-09 | 2005-10-27 | Sucampo Pharmaceuticals Inc. | Pharmaceutical compositions comprising fk506 derivatives and their use for the treatment of allergic diseases |
| US7354574B2 (en) | 2002-11-07 | 2008-04-08 | Advanced Ocular Systems Limited | Treatment of ocular disease |
| AR042890A1 (es) * | 2003-01-16 | 2005-07-06 | Sucampo Pharmaceuticals Inc | Metodo de tratamiento del ojo seco con una composicion oftalmica que contiene un compuesto macrolido |
| US7220422B2 (en) * | 2003-05-20 | 2007-05-22 | Allergan, Inc. | Methods and compositions for treating eye disorders |
| US7083802B2 (en) | 2003-07-31 | 2006-08-01 | Advanced Ocular Systems Limited | Treatment of ocular disease |
| AU2004274026A1 (en) | 2003-09-18 | 2005-03-31 | Macusight, Inc. | Transscleral delivery |
| US7087237B2 (en) | 2003-09-19 | 2006-08-08 | Advanced Ocular Systems Limited | Ocular solutions |
| US7083803B2 (en) | 2003-09-19 | 2006-08-01 | Advanced Ocular Systems Limited | Ocular solutions |
| CA2597590A1 (en) | 2005-02-09 | 2006-08-17 | Macusight, Inc. | Formulations for ocular treatment |
| US8663639B2 (en) | 2005-02-09 | 2014-03-04 | Santen Pharmaceutical Co., Ltd. | Formulations for treating ocular diseases and conditions |
| WO2007092620A2 (en) | 2006-02-09 | 2007-08-16 | Macusight, Inc. | Stable formulations, and methods of their preparation and use |
| US8222271B2 (en) * | 2006-03-23 | 2012-07-17 | Santen Pharmaceutical Co., Ltd. | Formulations and methods for vascular permeability-related diseases or conditions |
| US8536190B2 (en) * | 2007-01-30 | 2013-09-17 | Allergan, Inc. | Treating unwanted ocular conditions using an ascomycin macrolactam |
| WO2015188126A1 (en) * | 2014-06-06 | 2015-12-10 | The Schepens Eye Research Institute, Inc. | Compositions and methods for treating tumors and immune based inflammatory diseases |
| PL3470059T3 (pl) * | 2015-01-26 | 2020-11-30 | Bausch & Lomb Incorporated | Kompozycja zawiesiny okulistycznej |
| KR101710412B1 (ko) | 2015-09-15 | 2017-02-27 | 인제대학교 산학협력단 | Ycg063을 유효성분으로 함유하는 염증성 안구질환 예방 또는 치료용 약학조성물 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4894366A (en) * | 1984-12-03 | 1990-01-16 | Fujisawa Pharmaceutical Company, Ltd. | Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
| AU635286B2 (en) * | 1989-07-05 | 1993-03-18 | Astellas Pharma Inc. | Aqueous liquid composition for external use |
| NZ235991A (en) * | 1989-11-09 | 1993-05-26 | Sandoz Ltd | Macrolide compounds and pharmaceutical compositions thereof |
| IE65341B1 (en) * | 1990-11-08 | 1995-10-18 | Fujisawa Pharmaceutical Co | Suspensions containing tricyclic compounds |
| KR100237715B1 (ko) * | 1991-04-26 | 2000-02-01 | 후지야마 아키라 | 안과질환에 대한 마크로라이드 화합물의 용도 |
| AR004480A1 (es) * | 1995-04-06 | 1998-12-16 | Amico Derin C D | Compuestos de ascomicina que poseen actividad antiinflamatoria, pro cedimiento para prepararlos, uso de dichos compuestos para preparar agentesfarmaceuticos y composiciones farmaceuticas que los incluyen |
-
2002
- 2002-04-11 AR ARP020101334A patent/AR033151A1/es not_active Application Discontinuation
- 2002-04-12 EP EP02717124A patent/EP1379247A1/en not_active Withdrawn
- 2002-04-12 BR BR0208939-4A patent/BR0208939A/pt not_active IP Right Cessation
- 2002-04-12 MX MXPA03009273A patent/MXPA03009273A/es unknown
- 2002-04-12 US US10/120,515 patent/US20020187998A1/en not_active Abandoned
- 2002-04-12 WO PCT/JP2002/003664 patent/WO2002085359A1/en not_active Ceased
- 2002-04-12 NZ NZ529255A patent/NZ529255A/en unknown
- 2002-04-12 KR KR10-2003-7013323A patent/KR20040007494A/ko not_active Withdrawn
- 2002-04-12 JP JP2002582932A patent/JP2004529928A/ja not_active Abandoned
- 2002-04-12 CN CNA028082001A patent/CN1503671A/zh active Pending
- 2002-04-12 CA CA002445508A patent/CA2445508A1/en not_active Abandoned
-
2003
- 2003-10-10 NO NO20034560A patent/NO20034560L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US20020187998A1 (en) | 2002-12-12 |
| JP2004529928A (ja) | 2004-09-30 |
| KR20040007494A (ko) | 2004-01-24 |
| BR0208939A (pt) | 2004-04-20 |
| NZ529255A (en) | 2006-09-29 |
| NO20034560L (no) | 2003-12-09 |
| EP1379247A1 (en) | 2004-01-14 |
| NO20034560D0 (no) | 2003-10-10 |
| CN1503671A (zh) | 2004-06-09 |
| CA2445508A1 (en) | 2002-10-31 |
| MXPA03009273A (es) | 2004-02-12 |
| WO2002085359A1 (en) | 2002-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR033151A1 (es) | Agente para el tratamiento oftalmico topico de las enfermedades inflamatorias oculares | |
| MX2022007276A (es) | Tratamiento de la esclerosis amiotrofica lateral y enfermedades relacionadas. | |
| ATE355374T1 (de) | Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen | |
| EA200602130A1 (ru) | Замещенные арилацилтиомочевины и родственные соединения; ингибиторы репликации вирусов | |
| AR032556A1 (es) | Medicamento de accion inmediata para el tratamiento de la disfuncion sexual | |
| EA200702445A1 (ru) | Соединения тиазола и способы их применения | |
| ES2069410T3 (es) | Nuevos derivados del acido hidroxamico y n-hidroxiurea y su uso. | |
| BR0312232A (pt) | Inibidores de caspases e seus usos | |
| CR6963A (es) | Formas de sal de amida de acido 3.(4-bromo-2,6-difluoro-benciloxi)-5-(3-(4-piprolidin-1-ilbutil)ureido)isotiazol-4-carboxilico y metodo de produccion | |
| EA201490163A1 (ru) | Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения | |
| DK0868909T3 (da) | Opthalmisk bæreropløsning | |
| MX2021016055A (es) | Formulaciones y métodos de parasiticidas de isoxazolina para el tratamiento de la blefaritis. | |
| BR9914419A (pt) | Terapia para melhoria da percepção | |
| PA8542901A1 (es) | Uso de (z)-2-ciano-3-hidroxi-but-2-acido enoico-(4-trifluorometilfenil)-amida para tratar la esclerosis multiple | |
| JP2004529928A5 (es) | ||
| ES2393927T5 (es) | Composiciones tópicas | |
| MX2023004537A (es) | Compuestos y metodos para el tratamiento de trastornos oculares. | |
| CY1110644T1 (el) | 5,6,7-τριυδροξυεπτανοϊκο οξυ και τα αναλογα για την θεραπεια οφθαλμικων ασθενειων που σχετιζονται με υπερεκφυτικες και αγγειογενεις αντιδρασεις | |
| BRPI0407693A (pt) | uso de esteróides para preparação de formulações utilizáveis no tratamento de pessoas sofrendo de distúrbios oculares, bem como formulação assim obtidos | |
| ES2129448T3 (es) | Uso de 2-(2-nitro-4-trifluorometilbenzoil)-1,3-ciclohexanodiona en el tratamiento de tirosinemia y composiciones farmaceuticas. | |
| ES2215493T1 (es) | Agente farmacologico que comprende acido picolinico, acido fusarico y sus derivados. | |
| AR034866A1 (es) | Comprimido que comprende cetirizina y pseudoefedrina | |
| ES2341789T3 (es) | Composiciones oftalmicas y metodos de uso de las mismas. | |
| RU2008102249A (ru) | Профилактический или терапевтичесский агент для корнеального /конъюнктивального заболевания | |
| AR036009A1 (es) | Composicion farmaceutica para el tratamiento o prevencion del dolor visceral y los trastornos gastrointestinales que comprenden un compuesto aminoácido biciclico y uso de este ultimo para fabricar dicha composicion farmaceutica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |